185 related articles for article (PubMed ID: 37514014)
1. Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy.
Yao P; Wang X; Wang Q; Dai Q; Peng Y; Yuan Q; Mou N; Lv S; Weng B; Wang Y; Sun F
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514014
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
4. Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel.
Li B; Zhang XX; Huang HY; Chen LQ; Cui JH; Liu Y; Jin H; Lee BJ; Cao QR
Int J Pharm; 2018 May; 543(1-2):8-20. PubMed ID: 29535039
[TBL] [Abstract][Full Text] [Related]
5. Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer.
Badparvar F; Marjani AP; Salehi R; Ramezani F
Sci Rep; 2024 Apr; 14(1):8567. PubMed ID: 38609391
[TBL] [Abstract][Full Text] [Related]
6. Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy.
Li Y; Chen M; Yao B; Lu X; Song B; Vasilatos SN; Zhang X; Ren X; Yao C; Bian W; Sun L
Small; 2020 Aug; 16(32):e2002188. PubMed ID: 32627387
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
10. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle.
Swetha KL; Paul M; Maravajjala KS; Kumbham S; Biswas S; Roy A
J Control Release; 2023 Apr; 356():93-114. PubMed ID: 36841286
[TBL] [Abstract][Full Text] [Related]
11. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
12. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: Preparation, characterization and antitumor efficacy in vivo and in vitro.
Zuo T; Guan Y; Chang M; Zhang F; Lu S; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2016 Nov; 147():90-99. PubMed ID: 27497073
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
Nie J; Cheng W; Peng Y; Liu G; Chen Y; Wang X; Liang C; Tao W; Wei Y; Zeng X; Mei L
Drug Deliv; 2017 Nov; 24(1):1124-1138. PubMed ID: 28789585
[TBL] [Abstract][Full Text] [Related]
14. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
16. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
Tao J; Diao L; Chen F; Shen A; Wang S; Jin H; Cai D; Hu Y
Mol Pharm; 2021 Jan; 18(1):74-86. PubMed ID: 33084332
[TBL] [Abstract][Full Text] [Related]
18. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
20. cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma.
Zhong P; Qiu M; Zhang J; Sun H; Cheng R; Deng C; Meng F; Zhong Z
Nanotechnology; 2017 Jul; 28(29):295103. PubMed ID: 28574851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]